Microdose Edibles is the practice of taking very small amounts (one-tenth to one-twentieth of a typical nonclinical dose) of psilocybin mushrooms in order to achieve subtle enhancements of mood, creativity, and focus while maintaining the ability to function at work, school, and social activities. People who microdose psilocybin believe that doing so can improve mental health symptoms, such as anxiety and depression, increase productivity, and reduce pain, among other benefits.
Research on psychedelic microdosing is emerging rapidly, with many positive reports from people who engage in this practice. However, scientific evidence is still scarce, and it is not yet clear if the reported effects are due to the drug’s pharmacological properties or from other psychological factors, such as positive expectancy, a safe and supportive setting, and a framework of intentionality.
Psilocybin Microdose Capsules: A Beginner’s Guide to Clarity, Focus & Mood Support
The few studies that have attempted to evaluate psilocybin’s efficacy as a psychedelic microdoser are limited in their design, and have not yet established the relative magnitude of any observed changes. One study that used a self-blinding protocol to approximate placebo control found that microdosers reported improvements in their emotional well-being, but that two-thirds of participants correctly guessed their condition, complicating the ability to discern true effects from placebo effects.
In another recent study, researchers analyzed the brain waves of 34 people who engaged in microdosing using a device called an EEG machine. While they found some intriguing subjective effects, such as an increased sense of creativity and happiness, and changes in certain EEG frequencies, the low-dose psilocybin did not significantly impact psychomotor or spatial performance.
